First author | Country | Type of study | Patient population, N | Early intubation, N | Late intubation, N | No intubation, N | Prior trial of HFNC or NIV, N | Female sex, % | Age, yearsa | SOFA at ICU admissiona |
---|---|---|---|---|---|---|---|---|---|---|
COVID-ICU Group [20] | France Switzerland Belgium | Multicenter, prospective | 4244 | 2635 | 741 | 810 | NA | 26.0 | 63.0 [54.0–71.0] | 5.0 [3.0–8.0] |
Grasselli [21] | Italy | Multicenter, retrospective | 3988 | 2929 | 164 | NA | NA | 20.0 | NA | NA |
Hernandez-Romieu [22]b | United States | Multicenter, retrospective | 175 | 133 | 42 | NA | 78 | 44.6 | 66.0 [56.0–75.0] | 9.0 [7.0–12.0] |
Karagiannidisc [13] | Germany | Multicenter, retrospective | 1727 | 1318 | 141 | 145 | 141 | 33.6 | 71.0 [60.0–79.0] | NA |
Leed [23] | Korea | Multicenter, retrospective | 47 | 23 | 16 | 8 | NA | 40.4 | 70.0 [63.0–77.0] | 3.6 (3.2) |
Mattae [24] | United States | Single-center, retrospective | 111 | 76 | 35 | NA | 81 | 46.0 | 68.0 (11.3) | 7.6 (3.2) |
Mellado-Artigas [25] | Spain Andorra | Multicenter, prospective | 468 | 312 | 49 | NA | 92 | 30.8 | 61.7 (11.5) | 5.8 (2.4) |
Pandyaf [26] | United States | Single-center, retrospective | 75 | 37 | 38 | NA | NA | 42.7 | 65.0 (14.3) | NA |
Roedl [27] | Germany | Multicenter, retrospective | 223 | 128 | 39 | 56 | 46 | 27.0 | 69.0 [58.0–77.5] | 5.0 [3.0–9.0] |
Saida [18] | Tunisia | Single-center, retrospective | 10 | 4 | 3 | 3 | 1 | 20.0 | 51.8 (6.3) | NA |
Siempos [14] | Greece | Single-center, retrospective | 42 | 14 | 18 | 6 | 11 | 19.0 | 65.0 [58.0–71.0] | 4.0 [4.0–6.0] |
Zuccon [19] | Italy | Single-center, retrospective | 54 | 25 | 23 | 6 | 23 | 18.5 | NA | NA |